Upsher Smith’s Morphine Sulfate ER Capsules Available

Upsher-Smith announced the availability of their Morphine Sulfate Extended-Release Capsules, a Schedule II controlled substance, which will be commercially available on September 4, 2013.

Morphine Sulfate Extended-Release Capsules are indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. In general, opioid analgesics act primarily at the mu-receptors. Higher dosages, however, may result in activity at the other receptor subtypes.

Morphine Sulfate Extended-Release Capsules will be available in seven dosage strengths: 10mg, 20mg, 30mg, 50mg, 60mg, 80mg, and 100mg.

For more information call (800) 654-2299 or visit